Freshly Printed - allow 10 days lead
Couldn't load pickup availability
Nicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases
Overview of Epidemiological Data on Smoking and Preclinical and Clinical Data on Nicotine
Novel, comprehensive review of the epidemiological data on smoking, several neurological disorders, and the potential neuroprotection effect of tobacco compounds
Emilija Veljkovic (Author), Wenhao Xia (Author), Blaine Phillips (Author), Ee Tsin Wong (Author), Jenny Ho (Author), Alberto Oviedo Casado (Author), Julia Hoeng (Author), Manuel C. Peitsch (Author)
9780128129227, Elsevier Science
Hardback, published 3 January 2018
164 pages
22.9 x 15.1 x 1.8 cm, 0.39 kg
Nicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases: Epidemiological Data on Smoking and Preclinical and Clinical Data on Nicotine provides a comprehensive summary of the epidemiological data on smoking and several neurological disorders, including Alzheimer’s disease, Parkinson’s disease, Multiple Sclerosis, Tourette’s syndrome, schizophrenia, anxiety, depression and ADHD, as well as preclinical and clinical data on the effects of nicotine. Despite the obvious and undisputed harmful nature of smoking, evidence suggests that some tobacco and tobacco smoke-derived constituents may offer neuroprotective effects, possibly in combinations, rather than individually. This unprecedented book describes the complex relationships between smoking and neurological disease and the bioactive compounds found in tobacco. It provides a comprehensive review of nicotine and other compounds found in tobacco plant, with scientific evidence of neuroprotective and anti-inflammatory effects that may act in conjunction with nicotine to exert neuroprotective effects observed in smokers. By presenting findings beyond harmful cigarette smoke effects, attention can be drawn to individual compounds of tobacco that may serve as inspiration for further therapy development.
1. Multiple sclerosis2. Parkinson’s disease3. Alzheimer's disease4. Tourette syndrome5. Attention Deficit Hyperactivity Disorder in children and adults6. Schizophrenia7. Depression8. Anxiety9. Active principles from tobacco or smoke10. Animal and cellular models of MS, AD and PD and major consideration for translatability11. Conclusion remarks12. References
Subject Areas: Neurosciences [PSAN], Clinical & internal medicine [MJ]
